|
Volumn 356, Issue 13, 2007, Pages 1379-
|
Glycemic durability of monotherapy for diabetes [15]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLUCOSE;
THIAZIDE DIURETIC AGENT;
ANTIDIABETIC AGENT;
GLIBENCLAMIDE;
ROSIGLITAZONE;
GLYCOSYLATED HEMOGLOBIN;
2,4 THIAZOLIDINEDIONE DERIVATIVE;
METFORMIN;
CORONARY ARTERY DISEASE;
DIABETES MELLITUS;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HUMAN;
LETTER;
PRIORITY JOURNAL;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
OUTCOME ASSESSMENT;
QUALITY OF LIFE;
DEATH;
DECISION MAKING;
RISK FACTOR;
CELL FUNCTION;
HOMEOSTASIS;
BLOOD;
CARDIOVASCULAR DISEASE;
METABOLISM;
DRUG EFFECT;
PANCREAS ISLET BETA CELL;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
OUTCOME ASSESSMENT (HEALTH CARE);
QUALITY OF LIFE;
ANTIHYPERTENSIVE AGENTS;
BLOOD GLUCOSE;
CARDIOVASCULAR DISEASES;
HEMOGLOBIN A, GLYCOSYLATED;
GLYBURIDE;
INSULIN-SECRETING CELLS;
METFORMIN;
THIAZOLIDINEDIONES;
|
EID: 34047156056
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (5)
|
References (5)
|